一、ALIGNEDGENETICSINC投资情况:ALIGNEDGENETICSINC目前是上海锣格斯生命科技有限公司直接控股股东,持股比例为100%;目前ALIGNEDGENETICSINC投资上海锣格斯生命科技有限公司最终收益股份为100%;二、ALIGNEDGENETICSINC的商业合作伙伴:基于公开数据展示,ALIGNEDGENETICSINC与JUNGNEONCHEOL、JUNGYEONSEOK为商业合作伙伴。 财产...
Aligned Genetics, Inc. engages in commercializing technologies to support the life science research community. Its products include cell counter, digital microscope, and x-clarity. The firm also involved in the advancement of automated systems and imaging instruments for laboratories focused on research ...
以下为Aligned Genetics IncWACC数据要点 表现汇总 Aligned Genetics的wacc是8.5% 相比竞争对手,Aligned Genetics的WACC基准如何? 我们发现下列公司与Aligned Genetics Inc相近,它们都属于相关的行业。我们还考虑了规模、增长和各种财务指标,并将列表缩小到以下范围。 Aligned Genetics的WACC基准 名称代码WACC Aligned Genetics...
Disember 2019至 2023的财年,Aligned Genetics的税后净经营利润(nopat)中值为1.896十亿。 过去5年,Aligned Genetics的税后净经营利润(nopat)在Disember 2023达到了 2.903十亿的峰值。 Aligned Genetics的税后净经营利润(nopat)于Disember 2019触及5年低点,是-347.1百万。 Aligned Genetics的税后净经营利润(nopat)于最近5个...
Download Aligned Genetics Inc. stock data: historical 238120 stock prices from MarketWatch.
Aligned Genetics Aligned Genetics公司成立于2008年,是一家开发创新技术和产品以开启生命科学和分子诊断未来的公司。其前身Logos Biosystems专注于生命科学解决方案——生物分子分析,致力于通过‘超越细胞观察’来改善人类的健康。其产品可见于生命科学、神经学、细胞生物学、生物工艺、肿瘤学、农业、环境科学及许多其他研究...
Aligned genetic linkage maps of apple rootstock cultivar 'JM7' and Malus sieboldii 'Sanashi 63' constructed with novel EST-SSRs[J].Tree Genetics & Genomes 2012,4(4).Moriya S, Iwanami H, Kotoda N, Haji T, Okada K, Terakami S, Mimida N, Yamamoto T, Abe K (2012). Aligned genetic ...
Nature Reviews Genetics 14, 681–691 (2013). Article CAS PubMed Google Scholar Laehnemann, D., Borkhardt, A. & McHardy, A. C. Denoising dna deep sequencing data—high-throughput sequencing errors and their correction. Briefings in bioinformatics 17, 154–179 (2016). Article CAS PubMed ...
Department of Medical & Molecular Genetics, Faculty of Life Sciences and Medicine, King’s College London, London, UK Cathryn M. Lewis Contributions Conceptualisation, MK, OP, CML, and MR; methodology, MK, OP, CML, and MR; formal analysis, MK, and OP; investigation, MR; resources, MR; ...
December 2019至 2023的财年,Aligned Genetics的总债务/ebitda中值为1.6x。 过去5年,Aligned Genetics的总债务/ebitda在December 2019达到了 4.0x的峰值。 Aligned Genetics的总债务/ebitda于December 2023触及5年低点,是1.2x。 Aligned Genetics的总债务/ebitda于2020 (2.7x, -33.8%)、2021 (1.6x, -38.9%)、2022...